About this document
Advances in Triple-Negative Breast Cancer by Gabrielle Nascimento is a document available to read on EtoBox.
The review discusses the evolution of therapeutic targets for triple-negative breast cancer (TNBC) over the past two decades, highlighting its high heterogeneity and poor prognosis. Recent advancements in molecular understanding have led to the identification of various subtypes and new treatment strategies, including immunotherapy and PARP inhibitors. The review emphasizes the importance of molecular classification and biomarkers in guiding therapeutic decisions for TNBC patients.
- Author
- Gabrielle Nascimento
- Language
- EN